The Food and Drug Administration inspected CSL Plasma, Inc. in Orange City on April 16 for blood and blood products, according to data posted on the FDA’s website.
The inspection’s final report states that CSL Plasma, Inc. was not required to implement any changes regarding its management operations.
The FDA regularly audits facilities nationwide to verify that workplaces and their products comply with FDA-regulated standards and laws intended to protect public health. These inspection outcomes are made available to the public.
According to the agency’s website, the FDA is a government body mainly tasked with overseeing the production and distribution of human and animal drugs, biological products, medical supplies and tobacco items to ensure safety and quality.
Information in this article was sourced from the U.S. Food and Drug Administration. The source data is accessible here.
